MIRA INFORM REPORT

 

 

Report Date :

21.04.2012

 

IDENTIFICATION DETAILS

 

Name :

NULINK CO LTD JAPAN

 

 

Registered Office :

2638-50 Yamazaki Noda City Chiba-Pref 278-0022

 

 

Country :

Japan

 

 

Financials (as on) :

30.09.2010

 

 

Date of Incorporation :

October 2003

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Import, wholesale of pharmaceutical materials, chemicals

 

 

No. of Employees :

3

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

Yen 300,000.00

Status :

Moderate

Payment Behaviour :

Slow

Litigation :

--

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name and address

 

NULINK CO LTD JAPAN

REGD NAME:    KK Nulink Japan

MAIN OFFICE:  2638-50 Yamazaki Noda City Chiba-Pref 278-0022 JAPAN

Tel: 047-124-5210      Fax: 047-124-3938

                                               

URL:                 N/A

 

 

ACTIVITIES

 

Import, wholesale of pharmaceutical materials, chemicals

 

BRANCHES   

 

Nil

 

 

OFFICERS

 

Hisamaro Garugu, ch

SUMIKO GARUGU, PRES                                                        

 

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY    

 

FINANCES        R/WEAK           A/SALES          Yen 39 M

PAYMENTS      SLOW              CAPITAL           Yen 3 M

TREND             UP        WORTH            Yen 2 M

STARTED         2003                 EMPLOYES      3

 

 

COMMENT

 

TRADING FIRM SPECIALIZING IN PHARMACEUTICAL MATERIALS.

FINANCIAL SITUATION CONSIDERED RATHER WEAK BUT SHOULD BE GOOD FOR MODERATE BUSINESS ENGAGEMENTS.

                       

MAX CREDIT LIMIT: YEN 300,000.00, 30 DAYS NORMAL TERMS

 

HIGHLIGHTS

           

            The subject company was established by Hisamaro Garugu in order to make most of his experience in the pharmaceutical business.  He is an Indian resident, graduated from Tokyo University and worked at Eisai Co Ltd, major pharmaceutical mfr, Tokyo.  He is now advisor of Eisai Co Ltd.  Sumiko is his wife.  This is a trading firm specializing in import and wholesale of pharmaceuticals materials & chemicals.  Imports from India, China, other.  Clients include Eisai Co and other pharmaceutical makers.  The firm arranged to establish a JV in May 2011 between Kokuyo Co Ltd, top-ranked mfr of office supplies, Tokyo and Camlin Ltd, India, named Kokuyo Camlin Ltd, capital Indian Rupee 67.9 million, Kokuyo owning 50.3% share of the JV.

 

 

FINANCIAL INFORMATION

           

            The sales volume for May/2011 fiscal term amounted to Yen 39 million, a 3% up from Yen 38 million in the previous term.  The net profit was posted at Yen a minimum amount post-taxes, compared with Yen 1 million net losses a year ago.

 

            For the current term ending May 2012 the net profit is projected at Yen 3 million, on a 7% rise in turnover, to Yen 42 million. 

 

The financial situation is considered RATHER WEAK but should be good for MODERATE business engagements.  Max credit limit is estimated at Yen 300,000.00, on 30 days normal terms.

 

 

REGISTRATION

 

Date Registered:  Oct 2003

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         240 shares

Issued:                60 shares

Sum:                   Yen 3 million

Major shareholders (%): Hisamaro Garage & Sumiko Garugu (--100)

No. of shareholders: 2

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Imports and wholesales pharmaceutical raw materials, chemicals (--100%)

 

Clients: [Pharmaceutical mfrs, wholesalers] Eisai Co, Sawai Pharmaceutical Co, Pola Inc, other

No. of accounts: 30

Domestic areas of activities: Centered in greater-Tokyo

Suppliers: [Mfrs, wholesalers] Imports from India, China, other

 

Payment record: Slow

 

Location: Business area in Noda City, Chiba-Pref.  Office premises at the caption address are owned by Hisamaro Garugu as his private home residence and maintained satisfactorily.

 

Bank References:

Tokyo Bay Shinkin Bank (Edogawadai)

Bank of China (Edogawadai)

Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

       Terms Ending:

30/09/2011

30/09/2010

30/09/2009

30/09/2008

Annual Sales

　

39

38

27

22

Recur. Profit

　

　

-1

2

　

Net Profit

　

0

-1

3

　

Total Assets

　

　

48

41

32

Current Assets

　

　

5

3

　

Current Liabs

　

　

46

39

　

Net Worth

　

　

2

3

1

Capital, Paid-Up

　

　

3

3

3

Div.P.Share(₯)

　

　

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

2.63

40.74

22.73

..

    Current Ratio

 

..

10.87

7.69

..

    N.Worth Ratio

..

4.17

7.32

3.13

    R.Profit/Sales

 

..

-2.63

7.41

..

    N.Profit/Sales

0.00

-2.63

11.11

0.00

 

Notes: Resulted/confirmed figures for the 31/05/2011 fiscal term.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.52.00

UK Pound

1

Rs.83.54

Euro

1

Rs.68.40

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.